Phase II Study of Biweekly Plitidepsin as Second-Line Therapy for Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Por Dumez, Herlinde, Gallardo, Enrique, Culine, Stephane, Galceran, Joan Carles, Schöffski, Patrick, Droz, Jean P., Extremera, Sonia, Szyldergemajn, Sergio, Fléchon, Aude
Publicado em 2009

Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis

Por Carmen Kahatt, Cinthya Coronado, Pilar Lardelli, Claudia Silvia Corrado, Elena Roy, Vicente Alfaro, Bernardo Miguel-Lillo, Sonia Extremera, Arturo Soto-Matos, Sergio Szyldergemajn
Publicado em 2011-06-01

Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis

Por Soto-Matos, Arturo, Szyldergemajn, Sergio, Extremera, Sonia, Miguel-Lillo, Bernardo, Alfaro, Vicente, Coronado, Cinthya, Lardelli, Pilar, Roy, Elena, Corrado, Claudia Silvia, Kahatt, Carmen
Publicado em 2011

Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma

Por Plummer, R, Lorigan, P, Brown, E, Zaucha, R, Moiseyenko, V, Demidov, L, Soriano, V, Chmielowska, E, Andrés, R, Kudryavtseva, G, Kahatt, C, Szyldergemajn, S, Extremera, S, de Miguel, B, Cullell-Young, M, Calvert, H
Publicado em 2013

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin’s lymphoma

Por Ribrag, Vincent, Caballero, Dolores, Fermé, Christophe, Zucca, Emanuele, Arranz, Reyes, Briones, Javier, Gisselbrecht, Christian, Salles, Gilles, Gianni, Alessandro M., Gomez, Henry, Kahatt, Carmen, Corrado, Claudia, Szyldergemajn, Sergio, Extremera, Sonia, de Miguel, Bernardo, Cullell-Young, Martin, Cavalli, Franco
Publicado em 2013